Geneva, June 20 -- International Clinical Trials Registry received information related to the study (ISRCTN22295060) titled 'Performance evaluation of type 1 diabetes genetic risk test' on June 12.
Study Type: Observational
Study Design:
Single centre observational study using left over samples (Diagnostic)
Primary Sponsor: Randox Laboratories Limited
Condition:
Discrimination of Type 1 Diabetes from other non-autoimmune diabetes such as type 2 diabetes, monogenic diabetes or secondary diabetes.
Nutritional, Metabolic, Endocrine
Intervention:
An observational clinical performance study will be conducted to demonstrate that, under the anticipated conditions of use, the Type 1 Diabetes (T1D) SNP Array will meet the intended use and...